Example: Heart Attack

Search clinical trials for: Talaporfin

Total 13 results

NCT00716469

Terminated

Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas

Conditions: Neurofibroma
NCT00918034

Completed

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Conditions: Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
NCT00102115

Terminated

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Conditions: Macular Degeneration; Choroidal Neovascularization
NCT01924273

Completed

Novel Treatment for Port Wine Stain Birthmarks

Conditions: Port-Wine Stain
NCT00122876

Completed

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Conditions: Carcinoma, Hepatocellular; Liver Neoplasms
NCT00355355

Completed

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Conditions: Carcinoma, Hepatocellular; Liver Neoplasms
NCT00709488

Completed

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Conditions: Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
NCT02326454

Completed

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Conditions: Benign Prostatic Hyperplasia
NCT00028405

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Conditions: Liver Metastasis; Pelvic Cancer; Head and Neck Cancer; Sarcoma; Rectal Cancer; Breast Cancer; Colorectal Cancer; Mouth Cancer
NCT00068068

Completed

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
NCT00409214

Completed

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Conditions: Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
NCT00440310

Completed

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Conditions: Liver Metastases; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local
NCT00083785

Completed

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis